KR Downtime TONIGHT: 7pm-8pm

KR Downtime TONIGHT: 7pm-8pm

Dear Colleagues, Kuali Research (KR) will be down tonight from 7PM thru 8PM for the monthly deploy. One particular update we’d like to highlight is the change in the Annual Disclosure and the Personnel Tab in KR in order to satisfy the National Science Foundation requirement that institutions maintain records of foreign agreements of its NSF senior/key…

Read More

SAVE THE DATE: Topic-Specific QRAM (07/15)

SAVE THE DATE: Topic-Specific QRAM (07/15)

Dear Colleagues: Please mark your calendars for an off-cycle Quarterly Research Administration Meeting (QRAM) on Wednesday, July 15, 2026 from 2:00-3:00PM. Sponsored Projects will be hosting this topic-specific QRAM on international collaborations in federally sponsored projects. During this session, we will review proposed changes to the Uniform Guidance, specifically the updates covering foreign collaborations and…

Read More

ZOT IRB/hSCRO – Scheduled Maintenance on June 22, 2026, 6PM

ZOT IRB/hSCRO – Scheduled Maintenance on June 22, 2026, 6PM

Dear ZOT IRB/hSCRO Users, Please be advised that ZOT IRB/hSCRO will be unavailable on June 22, 2026, starting at 6:00 PM PST for approximately 30 minutes due to a scheduled system patch to address a minor bug. Please plan accordingly and avoid accessing the system during this time. The system will resume normal operation once…

Read More

Fed Update: COGR News Digest

Fed Update: COGR News Digest

Follow COGR on LinkedIn 6/16/26Forbes   Trump’s Research Policies Are Rattling The Career Plans Of Young Scientists A new NBER study reveals the Trump administration's 2025 federal science policies are significantly deterring young biomedical researchers. A survey of doctoral students and postdocs showed a sharp decline in their intent to remain in U.S. academia, with…

Read More

Immunology researcher secures nearly $4 million NIH grant to advance therapeutic vaccine to help end genital herpes

Irvine, Calif., June 16, 2026 — University of California, Irvine immunologist Lbachir BenMohamed has been awarded a $3.93 million National Institutes of Health grant to develop and test a novel therapeutic vaccine designed to prevent recurrent genital herpes, a lifelong viral infection that affects more than 60 million Americans and over 530 million people worldwide.…

Read More